THE APEX TIMES
A Dutch institute said counterfeit ecstasy tablets made to resemble U.S. President Donald Trump are being linked to dangerously high concentrations of PMMA, a compound that can cause severe toxicity and deaths.
Dutch authorities have been warned about counterfeit ecstasy tablets designed to resemble President Donald Trump, after a Dutch drug testing institute said laboratory results indicated the pills contain high levels of PMMA, a substance associated with severe overdoses. The warning was reported by CBS News on August 29, 2026, citing findings from the institute that analyzed seized drug samples.
According to the report, the institute said the “Trump-shaped” tablets are not typical MDMA ecstasy. Instead, the testing indicated a high concentration of PMMA, which can be more dangerous than MDMA for users who expect the effects of standard ecstasy pills. The institute said the formulation could be potentially lethal, underscoring the risk to people who may unknowingly take misrepresented drugs.
CBS News said the institute’s analysis focused on the chemical composition of the pills and that the shape and branding were intended to make the product appear authentic or recognizable. The report did not describe any specific quantities or how the samples were originally obtained beyond stating that they were analyzed as part of drug testing work.
PMMA is sometimes sold in markets using ecstasy branding, but it carries a different toxicity profile. The CBS report emphasized that the institute’s concern was not the pill’s appearance, but its chemical makeup, which can lead to dangerous outcomes for users relying on expected dosing and effects.
The warning comes amid broader European scrutiny of synthetic drugs and adulterated substances. When pills sold as ecstasy contain alternative drugs or higher-than-expected concentrations, law enforcement and health agencies can face delayed identification of threats, because users and emergency responses may initially treat poisonings as typical ecstasy reactions.
The institute’s statement, as reported by CBS News, adds to the public safety message that pill appearance is not a reliable indicator of contents. It also raises the possibility that additional batches with similar branding could be circulating, depending on production and distribution patterns.
For now, the practical next step described in the report is continued lab testing and public alerts tied to chemical findings, rather than marketing cues. Anyone encountering drugs shaped or marketed as “ecstasy,” particularly those bearing high-profile political or celebrity likenesses, would be at increased risk if the product is mislabeled or contains PMMA at dangerous concentrations.
